This study represents the first published data on antimicrobial susceptibility of Asian isolates of Lawsonia intracellularis. We assessed MICs of 16 antimicrobials for two isolates of L. intracellularis recovered from diseased pigs in South Korea, one from a finisher pig with acute proliferative hemorrhagic enteropathy in 2002 and the other from a grower pig with porcine intestinal adenomatosis in 2010. Tylosin and tilmicosin were found to be the most active against L. intracellularis both intracellularly (MICs, 0.25 to 0.5 g/ml and 0.125 g/ml, respectively) and extracellularly (MICs, 0.25 to 0.5 g/ml and 1 g/ml, respectively).
Lawsonia intracellularis can cause acute intestinal hemorrhage (proliferative hemorrhagic enteropathy [PHE] ) in naïve adult pigs and a wasting disease (porcine intestinal adenomatosis [PIA]) in growing pigs (7, 11) . In vitro studies of the antimicrobial susceptibility of this obligate intracellular bacterium necessitate complicated cell culture systems (3, 5, 6, 12) , and only a few laboratories in the world perform antimicrobial susceptibility testing, because few L. intracellularis strains have been successfully isolated and maintained in culture (17) . Thus, while knowledge of the antimicrobial susceptibility of L. intracellularis is important for management and treatment decisions, published data on its in vitro antimicrobial sensitivity are very limited. There is only one previous field study of the antimicrobial resistance and susceptibility of L. intracellularis in the context of its treatment and control in Asia (8) . The study demonstrated that the administration of tylosin in the animal feed reduced infection rates on farms (8) . In this study, we compared the inhibitory activities of 16 antimicrobial agents against two L. intracellularis isolates from South Korea that were collected 8 years apart, with an emphasis on antimicrobials commonly used in pig production.
The following antimicrobial agents were purchased as pure chemicals from Sigma-Aldrich Korea (Yong-In Si, Republic of Korea): lincomycin hydrochloride, carbadox, ampicillin, penicillin G potassium salt, tiamulin hydrogen fumarate, chlortetracycline hydrochloride, bacitracin, polymyxin (colistin) sulfate, tylosin tartrate, gentamicin sulfate, kanamycin sulfate, neomycin sulfate, spectinomycin dihydrochloride, streptomycin sulfate, and enrofloxacin. Tilmicosin was supplied as a pure chemical by Elanco Animal Health Korea, Ltd. (Seoul, Republic of Korea). The L. intracellularis field isolates were obtained from infected pigs at farms located near each other in the same province (Hongseong-gun and Chungnam, Republic of Korea). A strain of L. intracellularis, termed the PHE/KK421 strain, was isolated from a finisher pig with acute PHE in 2002 (19) , and another strain, PIA/MyCoyL1, was isolated from a grower pig with PIA in 2010. In this study, isolates were prepared in McCoy cells and harvested as previously described (4). L. intracellularis was quantified as follows. First, 10-fold serial dilutions of the samples were made in phosphate-buffered saline (PBS; pH 7.2). Then, 12-well glass slides were coated with 10 l of each dilution and dried at 37°C for 30 min. Finally, the slides were fixed with cold acetone and stained by indirect immunoperoxidase activity using antiserum against L. intracellularis. Different sample dilutions were evaluated under the light microscope, and the dilution that could be accurately counted (50 to 500 bacteria) was recorded. Quantification of L. intracellularis was performed in duplicate. The concentrations of the L. intracellularis inocula were between 5.9 ϫ 10 5 and 7.1 ϫ 10 6 bacteria/ml. The MICs of each antimicrobial against L. intracellularis were determined using antimicrobial susceptibility testing and data analysis methodology as previously described (17) .
The susceptibilities of L. intracellularis to each of the antimicrobials are displayed in Table 1 . For both isolates, tilmicosin and tylosin displayed the greatest activity with MICs of 1.0 g/ml, while lincomycin, the peptide-type antimicrobials, and most of the aminoglycosides had the weakest activity. For the 2002 L. intracellularis isolate, tilmicosin, tylosin, carbadox, and tiamulin displayed the greatest intracellular activities, with MICs of 0.5 g/ml. In the extracellular activity assays, carbadox, ampicillin, penicillin G, tiamulin, chlortetracycline, and enrofloxacin all displayed moderate activities against this strain, with MICs ranging from 4 g/ml to 32 g/ml, whereas tilmicosin and tylosin displayed MICs of 0.5 g/ml and 1.0 g/ml, respectively. The MICs of the 2010 isolate using lincomycin, ampicillin, penicillin G, tiamulin, chlortetracycline, and enrofloxacin were higher than those for the 2002 isolate. However, there was no difference in the MIC values of these strains when tilmicosin, tylosin, and carbadox were used (Table 1) . Data on in vitro antimicrobial susceptibility for L. intracellularis are very limited, because the difficulty of maintaining and culturing L. intracellularis has resulted in a limited number of available strains. Reports regarding this organism involve low numbers of isolates from Europe and/or North America (12, 17) . Thus, McOrist et al. included only three isolates of L. intracellularis in a European study (12) , and Wattanaphansak et al. tested six isolates from North America and four from Europe in a U.S. study (17) . The present study represents the first antimicrobial susceptibility testing of L. intracellularis isolates from Asia. Given that South Korea has a high L. intracellularis prevalence, ranging from 40% to 100% herd prevalence (8, 16) , and that a high herd prevalence is present in other regions of Asia (e.g., Vietnam, 77%; China and the Philippines, 85 to 86%; Japan, 94%; Malaysia and Thailand, 100%) (10), our data are important preliminary first steps in assisting management and treatment decisions.
Reports from clinical trials supplying efficacy and pharmacokinetic data on antimicrobial compounds against L. intracellularis are still limited in Asia. Thus, the use of antimicrobial medication for the purpose of preventive medicine and treatment is supported by only a few clinical trial papers for lincomycin (1, 2, 14) , tylosin (9, 13), tiamulin (15) , and chlortetracycline (18) . A wide range of antimicrobials has been recommended for the treatment of pigs with L. intracellularis infection in Asia, but the recommendations have not been based on susceptibility testing in vitro. Therefore, this preliminary study gives the first insight into the relationship of in vitro antibiotic activity and clinical effectiveness reports in South Korea and, taken together with previously published data (12, 17) , should be used only as a guide to determine which antimicrobials could be effective in reducing or treating L. intracellularis infection and disease. Further in vivo studies are needed to confirm the antimicrobial efficacies against Asian isolates of L. intracellularis.
The intracellular and extracellular activities of lincomycin, tiamulin, chlortetracycline, spectinomycin, enrofloxacin, and the penicillin class of antimicrobials were two to eight times less effective against the 2010 isolate than against the isolate collected in 2002. With regard to susceptibility changes over time, these results contradict those of Wattanaphansak et al. (17) , which reveal no pattern of increased resistance over time among the North American and European strains of L. intracellularis.
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